You are here

  • Home
  • Archive
  • Volume 97, Issue 1
  • Can cardiac [123I]m-iodobenzylguanidine imaging be used for risk stratification of patients with acute myocardial infarction?

Article Text

Article menu
Download PDFPDF
Editorial
Can cardiac [123I]m-iodobenzylguanidine imaging be used for risk stratification of patients with acute myocardial infarction?

http://dx.doi.org/10.1136/hrt.2010.209007

Statistics from Altmetric.com

    Request Permissions

    If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

    Footnotes

    • Linked articles 204149.

    • Funding MJB supported by the Dutch Heart Foundation, grant 2006T102. JJB received research grants from Medtronic, Boston Scientific, Edwards Lifesciences, BMS Medical Imaging, St Jude Medical and GE Healthcare.

    • Competing interests None.

    • Provenance and peer review Commissioned; not externally peer reviewed.

    Linked Articles